William Federici Sells Shares of Stevanato Group
William Federici sold 1,493 shares of Stevanato Group, valued at $25,515.37, on June 15, 2026.
Key Points
- William Federici sold 1,493 shares of Stevanato Group at $17.09 each on June 15, 2026, totaling $25,515.37.
- Shares of NYSE:STVN traded near $18.39 on Friday, with a market cap of $5.02 billion and a P/E ratio of 31.7.
- Analysts like TD Cowen and Wolfe Research have buy ratings, with price targets as high as $32.00.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 15, 2026, William Federici sold 1,493 shares of Stevanato Group S.p.A. (NYSE:STVN) at an average price of $17.09 per share. The total transaction was valued at $25,515.37. This insider transaction was not part of a pre-planned trading program.
Insider Buying and Selling at Stevanato Group S.p.A.
Several other insiders at Stevanato Group were active on the same day. Karen Flynn, Madhavan Balachandran, and Donald Morel Jr. each sold 1,493 shares at the same price. Additionally, William Federici purchased 4,975 shares on June 12, 2026, without a specified price, and Marco Dal Lago, the Chief Financial Officer, also bought 2,356 shares that day.
Stevanato Group S.p.A. Stock Down 12.6%
Shares of Stevanato Group traded near $18.39 on Friday. The company, which operates in the healthcare sector, has a market capitalization of about $5.02 billion. It boasts a P/E ratio of 31.7 and a forward P/E of 21.9, indicating investor expectations of future earnings growth. The stock's beta of 0.776 suggests it is less volatile than the overall market. Over the past year, the stock has ranged from a low of $12.89 to a high of $28.00, with 50-day and 200-day moving averages of $17.39 and $19.57, respectively.
$STVN stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
In its most recent earnings report, Stevanato Group reported revenue of approximately $1.20 billion, reflecting a growth rate of 6.6%. The company achieved a net margin of 11.7% and a return on equity of 9.6%. Earnings per share stood at $0.58. The next earnings announcement is scheduled for May 7, 2026.
Analysts Set New Price Targets
On June 16, 2026, TD Cowen initiated coverage of Stevanato Group with a buy rating and a price target of $25.00. Earlier, on June 2, 2026, Wolfe Research assumed coverage with a buy rating and a target of $21.00. The consensus among analysts is a buy rating, with a mean price target of $24.45 based on 10 analyst opinions.
About Stevanato Group
Stevanato Group S.p.A., headquartered in Piombino Dese, Italy, designs and manufactures products for the biopharma and healthcare industries. Founded in 1949, the company operates through its Biopharmaceutical and Diagnostic Solutions and Engineering segments. It offers a range of products including drug containment solutions like syringes and vials, drug delivery systems, and diagnostic lab consumables. The company serves various sectors including pharmaceuticals, biotechnology, and diagnostics, and employs around 6,010 people.
Bottom Line
William Federici's recent sale of Stevanato Group shares is a notable transaction among the company's insiders. Investors often watch such moves to gauge insider sentiment. While this sale was significant, it doesn't necessarily indicate a negative outlook. As always, insider trades are just one piece of the investment puzzle.
Get Stevanato Group S.p.A. alerts
New 13F filings, insider trades, and analyst moves on $STVN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.